Akoya Biosciences, Inc.

AKYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$55-$63-$71-$43
Dep. & Amort.$8$9$7$5
Deferred Tax$0-$0$0-$0
Stock-Based Comp.$9$10$7$4
Change in WC-$14-$14$2-$5
Other Non-Cash$8$8$0$3
Operating Cash Flow-$44-$51-$53-$36
Investing Activities
PP&E Inv.-$2-$4-$7-$5
Net Acquisitions$0$0$0$0
Inv. Purchases-$104$0-$41$0
Inv. Sales/Matur.$83$7$34$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$24$3-$14-$5
Financing Activities
Debt Repay.-$1$11$31-$0
Stock Issued$0$48$0$139
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0-$1
Other Fin. Act.-$2-$2-$2$0
Financing Cash Flow-$3$57$29$137
Forex Effect$0$0$0$0
Net Chg. in Cash-$71$9-$39$96
Supplemental Information
Beg. Cash$84$75$113$18
End Cash$12$84$75$113
Free Cash Flow-$47-$55-$61-$41
Akoya Biosciences, Inc. (AKYA) Financial Statements & Key Stats | AlphaPilot